Ethosuximide-associated systemic lupus erythematosis in childhood

Hess, 1988, Drug-related lupus, N Engl J Med, 318, 1460, 10.1056/NEJM198806023182209 Solinger, 1988, Drug-related lupus: clinical and etiologic considerations, Rheum Dis Clin North Am, 14, 187, 10.1016/S0889-857X(21)00954-6 Jacobs, 1963, Systemic lupus erythematosus in childhood, Pediatrics, 32, 257, 10.1542/peds.32.2.257 Beernick, 1973, Anticonvulsant-induced antinuclear antibodies and lupus-like disease in children, J Pediatr, 82, 113, 10.1016/S0022-3476(73)80027-7 Singsen, 1976, Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants, Pediatrics, 57, 529, 10.1542/peds.57.4.529 Livingston, 1968, Systemic lupus erythematosis: occurrence in association with ethosuximide therapy, JAMA, 204, 185, 10.1001/jama.1968.03140210087025 Dabbous, 1970, Occurrence of systemic lupus erythematosus in association with ethosuccimide therapy, J Pediatr, 76, 617, 10.1016/S0022-3476(70)80418-8 Alter, 1970, Systemic lupus erythematosus and ethosuccimide, J Pediatr, 77, 1093, 10.1016/S0022-3476(70)80106-8 Dabbous, 1970, Systemic lupus erythematosus and ethosuccimide, J Pediatr, 77, 1094, 10.1016/S0022-3476(70)80107-X Lovisetto, 1985, Su un caso di lupus farmaco-indotto, Recent Prog Med, 76, 84 Harley, 1988, Autoantibodies, Rheum Dis Clin North Am, 14, 43, 10.1016/S0889-857X(21)00945-5 Fritzler, 1982, Clinical features of systemic lupus erythematosus patients with antihistone antibodies, J Rheumatol, 9, 46 Epstein, 1985, The diagnostic value of antihistone antibodies in drug-induced lupus erythematosus, Arthritis Rheum, 28, 158, 10.1002/art.1780280209 Totoritis, 1988, Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus, N Engl J Med, 318, 1431, 10.1056/NEJM198806023182204 Fielder, 1983, Family study of the major histocompatibility complex in patients with systemic lupus erythematosis: importance of null alleles of C4A and C4B in determining disease susceptibility, Br Med J, 286, 425, 10.1136/bmj.286.6363.425 Sim, 1984, Drugs that induce systemic lupus erythematosus inhibit complement component C4, Lancet, 2, 422, 10.1016/S0140-6736(84)92905-2 Spiers, 1989, Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus, Lancet, 1, 922, 10.1016/S0140-6736(89)92506-3 Howard, 1986, Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans, Am J Med, 81, 187, 10.1016/0002-9343(86)90250-0 Ahearn, 1982, Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosis, Arthritis Rheum, 25, 1031, 10.1002/art.1780250901 Bateman, 1985, Carbamazepine induced systemic lupus erythematosis: case report, Br Med J, 291, 632, 10.1136/bmj.291.6496.632 McNicholl, 1985, Carbamazepine induced systemic lupus erythematosis, Br Med J, 291, 1126, 10.1136/bmj.291.6502.1126 Alballa, 1987, A case of drug induced lupus due to carbamazepine, J Rheumatol, 14, 599 De Giorgio, 1991, Carbamazepine-induced antinuclear antibodies and systemic lupus erythematosus-like syndrome, Epilepsia, 32, 128, 10.1111/j.1528-1157.1991.tb05623.x Bleck, 1990, Possible induction of systemic lupus erythematosus by valproate, Epilepsia, 31, 343, 10.1111/j.1528-1157.1990.tb05386.x